The antimicrobial peptide, human β-defensin-1, potentiates in vitro osteoclastogenesis via activation of the p44/42 mitogen-activated protein kinases
© 2017 Elsevier Inc. Previous studies have demonstrated increased expression and raised levels of human β-defensin (hBD)-1 in gingival tissue and crevicular fluid of patients with chronic periodontitis and peri-implantitis, oral bone-resorbing diseases caused by enhanced osteoclastogenesis. Therefor...
Saved in:
Main Authors: | Makeudom A., Supanchart C., Montreekachon P., Khongkhunthian S., Sastraruji T., Krisanaprakornkit J., Krisanaprakornkit S. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85024853295&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40125 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
The antimicrobial peptide, human β-defensin-1, potentiates in vitro osteoclastogenesis via activation of the p44/42 mitogen-activated protein kinases
by: Anupong Makeudom, et al.
Published: (2018) -
The antimicrobial peptide, human β-defensin-1, potentiates in vitro osteoclastogenesis via activation of the p44/42 mitogen-activated protein kinases
by: Anupong Makeudom, et al.
Published: (2018) -
The antimicrobial peptide, LL-37, inhibits in vitro osteoclastogenesis
by: C. Supanchart, et al.
Published: (2018) -
The antimicrobial peptide, LL-37, inhibits in vitro osteoclastogenesis
by: Supanchart C., et al.
Published: (2014) -
The antimicrobial peptide, LL-37, inhibits in vitro osteoclastogenesis
by: Supanchart C., et al.
Published: (2014)